pros and cons to semaglutide Is Right for You? Exploring the Benefits Risks RACGP - Examining the pros

Ponatinib, a third-generation BCR-ABL inhibitor with potent activity against T315I-mutant leukemia, is under investigation in pediatric relapsed or refractory hematologic malignancies (NCT03934372)

Although it is rare, death in adults resulting from gastrointestinal complications has occurred in the past

Discuss your personal and family medical history with your GP, particularly any history of thyroid conditions or medullary thyroid carcinoma

Note: animal studies indicate that high doses of DPP-4 inhibitors & GLP-1 agonists cause expansion of cells of the pancreatic ductal glands and can cause premalignant pancreatic intraepithelial lesions (PanIN) that have the potential to progress to pancreatic adenocarcinoma

Ponath, G., Park, C

Note on insurance: For branded GLP-1s, prescriptions may be covered if filled at your pharmacy, depending on the insurance carrier